Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 (Q106610416)

From Wikidata
Jump to navigation Jump to search
scholarly article by Hanneke Schuitemaker published in 2021
edit
Language Label Description Also known as
English
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
scholarly article by Hanneke Schuitemaker published in 2021

    Statements

    Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 (English)
    0 references
    0 references
    0 references
    0 references
    Jerald Sadoff
    0 references
    Glenda Gray
    0 references
    An Vandebosch
    0 references
    Vicky Cárdenas
    0 references
    Georgi Shukarev
    0 references
    Paul A. Goepfert
    0 references
    Carla Truyers
    0 references
    Hein Fennema
    0 references
    Bart Spiessens
    0 references
    Kim Offergeld
    0 references
    Gert Scheper
    0 references
    Kimberly L. Taylor
    0 references
    Merlin L. Robb
    0 references
    John Treanor
    0 references
    Dan H. Barouch
    0 references
    Jeffrey Stoddard
    0 references
    Martin F. Ryser
    0 references
    Mary A. Marovich
    0 references
    Lawrence Corey
    0 references
    Nancy Cauwenberghs
    0 references
    Tamzin Tanner
    0 references
    Karin Hardt
    0 references
    Javier Ruiz-Guiñazú
    0 references
    Mathieu Le Gars
    0 references
    Johan Van Hoof
    0 references
    Frank Struyf
    0 references
    Macaya Douoguih
    0 references
    21 April 2021
    0 references

    Identifiers

    0 references
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit